Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy without gangrene
ICD-10 E09.51 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy without gangrene.
E09.51 refers to diabetes mellitus that is induced by drugs or chemicals, characterized by the presence of diabetic peripheral angiopathy without gangrene. This condition arises when certain medications or toxic substances disrupt normal glucose metabolism, leading to hyperglycemia and subsequent complications. Diabetic peripheral angiopathy is a vascular complication that affects blood flow to the extremities, resulting in symptoms such as pain, numbness, and increased risk of infections. The absence of gangrene indicates that while there is significant vascular compromise, tissue death has not yet occurred. Management of this condition typically involves controlling blood glucose levels through lifestyle modifications, oral hypoglycemics, or insulin therapy, alongside monitoring for and addressing complications such as neuropathy and peripheral vascular disease. Regular assessment of HbA1c levels is crucial to evaluate long-term glycemic control and adjust treatment plans accordingly.
Thorough documentation of diabetes type, treatment regimen, and complications.
Patients presenting with new-onset diabetes after starting a specific medication.
Ensure clear documentation of the drug responsible for the diabetes and any related complications.
Detailed notes on vascular assessments and interventions.
Patients with peripheral vascular disease secondary to diabetes.
Document the extent of vascular compromise and any surgical interventions performed.
Used for follow-up visits for diabetes management.
Document patient's diabetes management plan and any changes in medication.
Endocrinologists should ensure comprehensive notes on diabetes control.
Common drugs that can induce diabetes include corticosteroids, certain antipsychotics, and some antihypertensive medications. It is important to document the specific drug responsible for accurate coding.
